Evidence map›Paper›PMID 17192409›Full record

ArticleMolecular biology of the cell2007

Identification of an N-acetylglucosamine transporter that mediates hyphal induction in Candida albicans.

Francisco J Alvarez, James B Konopka

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 143 citations in OpenAlex.

  1. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Article
  3. mSphere · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Key sugar transporters drive development and pathogenicity inFrontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. A Special Phenotype of AconidialJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. From Jekyll to Hyde: The Yeast-Hyphal Transition ofPathogens (Basel, Switzerland) · 2021
    Review
  18. Microorganisms · 2021
    Article
  19. Review
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Francisco J AlvarezGraduate Program in Genetics, State University of New York, Stony Brook, NY 11794-5222, USA.
James B Konopka
Institut thématique Génétique, génomique et bioinformatique · FRState University of New York · US

Funding

Regulation of Morphogenesis in C. albicansR01AI047837 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2001 to 2026
$8.8M
NIAID NIH HHS R01 AI047837NIAID NIH HHS R01 AI47837
6 · The paper itself

Abstract

The sugar N-acetylglucosamine (GlcNAc) plays an important role in nutrient sensing and cellular regulation in a wide range of organisms from bacteria to humans. In the fungal pathogen Candida albicans, GlcNAc induces a morphological transition from budding to hyphal growth. Proteomic comparison of plasma membrane proteins from buds and from hyphae induced by GlcNAc identified a novel hyphal protein (Ngt1) with similarity to the major facilitator superfamily of transporters. An Ngt1-GFP fusion was detected in the plasma membrane after induction with GlcNAc, but not other related sugars. Ngt1-GFP was also induced by macrophage phagocytosis, suggesting a role for the GlcNAc response in signaling entry into phagolysosomes. NGT1 is needed for efficient GlcNAc uptake and for the ability to induce hyphae at low GlcNAc concentrations. High concentrations of GlcNAc could bypass the need for NGT1 to induce hyphae, indicating that elevated intracellular levels of GlcNAc induce hyphal formation. Expression of NGT1 in Saccharomyces cerevisiae promoted GlcNAc uptake, indicating that Ngt1 acts directly as a GlcNAc transporter. Transport mediated by Ngt1 was specific, as other sugars could not compete for the uptake of GlcNAc. Thus, Ngt1 represents the first eukaryotic GlcNAc transporter to be discovered. The presence of NGT1 homologues in the genome sequences of a wide range of eukaryotes from yeast to mammals suggests that they may also function in the cellular processes regulated by GlcNAc, including those that underlie important diseases such as cancer and diabetes.

Indexed as

AcetylglucosamineAnimalsBiological TransportCandida albicansCell MembraneEvolution, MolecularFungal ProteinsGene ExpressionGreen Fluorescent ProteinsHyphaeMacrophagesMass SpectrometryMicePhagocytosisPhosphoenolpyruvate Sugar Phosphotransferase SystemRecombinant Fusion ProteinsAcetylglucosamineacetylglucosamine transporterFungal ProteinsGreen Fluorescent ProteinsPhosphoenolpyruvate Sugar Phosphotransferase SystemRecombinant Fusion Proteins

Identifiers

PMID17192409
PMCPMC1805087
OpenAlexW2165120664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.